UCLA forms collaboration with Yuyu Pharma to develop drug for stroke recovery
UCLA has formed a research collaboration with South Korea-based Yuyu Pharma to develop drugs that could help people recover after a stroke.
Yuyu will develop drug candidates and UCLA researchers will conduct preclinical trials that could lead to further development of new compounds.
UCLA TDG is currently accepting submissions for the Pearl Cohen Poster Award Competition ($250 - $750 cash prizes) which is a unique opportunity to showcase your bioscience research programs in front of pharma and biotech industry leaders. All accepted submissions will be displayed during digital “Poster Plaza Session”, arranged by therapeutic area, with three presentation timeslots (complimentary admission included for the lead author). Award winners will be announced during the event.
In the two part series "Academia Meets The Market", In Vivo's William Looney interviews Amir Naiberg, associate vice chancellor and CEO & president of UCLA Technology Development Group to discuss the growth and strategy of tech transfer at UCLA through research, investments, partnerships, and programs.
Leading Universities Launch Joint Technology Licensing Program
UCLA created the Innovation Fund to bridge the gap between early-stage research and translation of life-impacting technology. Support the profound work that our faculty and researchers do right now with a tax-deductible donation.
Avenda Health, a software and medical device company that spun out of UCLA, announced today that the Food and Drug Administration (FDA) has cleared their focal laser ablation system.